Abstract
4-Hydroxy-4-methyl-2-oxoglutarate/4-carboxy-4-hydroxy-2-oxoadipate (HMG/CHA) aldolase from Pseudomonas putida F1 catalyzes the last step of the bacterial protocatechuate 4,5-cleavage pathway. The preferred substrates of the enzyme are 2-keto-4-hydroxy acids with a 4-carboxylate substitution. The enzyme also exhibits oxaloacetate decarboxylation and pyruvate α-proton exchange activity. Sodium oxalate is a competitive inhibitor of the aldolase reaction. The pH dependence of kcat/Km and kcat for the enzyme is consistent with a single deprotonation with pKa values of 8.0 ± 0.1 and 7.0 ± 0.1 for free enzyme and enzyme substrate complex, respectively. The 1.8 Å x-ray structure shows a four-layered α-β-β-α sandwich structure with the active site at the interface of two adjacent subunits of a hexamer; this fold resembles the RNase E inhibitor, RraA, but is novel for an aldolase. The catalytic site contains a magnesium ion ligated by Asp-124 as well as three water molecules bound by Asp-102 and Glu-199′. A pyruvate molecule binds the magnesium ion through both carboxylate and keto oxygen atoms, completing the octahedral geometry. The carbonyl oxygen also forms hydrogen bonds with the guanadinium group of Arg-123, which site-directed mutagenesis confirms is essential for catalysis. A mechanism for HMG/CHA aldolase is proposed on the basis of the structure, kinetics, and previously established features of other aldolase mechanisms.
Keywords: Enzyme Catalysis, Enzyme Kinetics, Enzyme Mechanisms, Enzyme Structure, Evolution, Metalloenzymes, Aldolase, Protocatechuate Degradation, Pyruvate, Xenobiotics
Introduction
Protocatechuate is a key intermediate in the microbial degradation of diverse aromatic compounds, including low molecular weight products derived from lignin degradation, such as vanillate and syringate (1), pollutants from fossil fuels and coal derivatives such as fluorene and its analogs (2), and man-made xenobiotics such as phthalate isomers found in plastics and pesticides (1, 3). The aromatic ring cleavage of protocatechuate in the microbial 4,5-cleavage pathway leads to formation of 4-carboxy-2-hydroxymuconate-6-semialdehyde. Depending on the bacteria strain, this intermediate can be converted to 4-hydroxy-4-methyl-2-oxoglutarate (HMG)3 in the hydrolytic branch of the pathway or 4-carboxy-4-hydroxy-2-oxoadipate (CHA) in the oxidative branch (4). Carbon-carbon bond cleavage catalyzed by a common aldolase (HMG/CHA aldolase; EC 4.1.3.17) leads to formation of two molecules of pyruvate in the former case and a molecule of pyruvate and oxaloacetate in the latter (Fig. 1), which can then be channeled to the TCA cycle (5).
Aldolases are an evolutionarily diverse class of enzymes that are typically divided into two groups based on their catalytic mechanism. The Class I aldolases utilize a Schiff base mechanism to stabilize a carbanion intermediate, whereas the Class II enzymes utilize divalent metal ions to stabilize an enolate intermediate. Within each mechanistic class of aldolases, further diversity exists with respect to the sequence, structure, and substrate specificities. HMG/CHA aldolases have previously been purified from Pseudomonas putida and Pseudomonas ochraceae and found to be divalent metal ion-dependent Class II aldolases (5, 6). However, the amino acid sequence of the P. orchraceae enzyme (7) showed no sequence similarity to other well studied Class II pyruvate aldolases, including HpaI (8) and DmpG (9) from the bacterial degradation pathways of 4-hydroxyphenylacetate and phenol, respectively. Therefore, HMG/CHA aldolases have been proposed to be distinct members of Class II pyruvate aldolases in aromatic degradation pathways (COG0684 for HMG/CHA aldolases, COG3836 for HpaI, and COG0119 for DmpG). Intriguingly, the HMG/CHA aldolases are distantly related in sequence to RraA (regulator of ribonuclease activity A) proteins (sequence identities of 25–33% over the central ∼115 residues and ∼15% over entire sequence), which associate within the RNA degradosome and inhibit RNase E activity in Escherichia coli (10), and a yeast protein (YER010c) of known structure but unknown function (11).
In addition to their importance in aromatic compounds and carbohydrate metabolism, the ability of aldolases to catalyze the formation of carbon-carbon bond linkages has resulted in them also being exploited as biocatalysts to synthesize natural products and bioactive molecules (12). Here, we kinetically characterize HMG/CHA aldolase from P. putida F1 (56% sequence identity to the P. orchracea enzyme), show that its structure is characterized by an RraA-like fold previously unseen in aldolases, and find conserved features in common with distantly related and poorly characterized homologs. Our results provide significant new insights into the active site organization and the potential catalytic mechanism of this enzyme, which should facilitate efforts to engineer aldolases to enhance aromatic pollutant degradation and for use as a biocatalyst.
EXPERIMENTAL PROCEDURES
Chemicals
Sodium pyruvate, sodium oxalate, oxaloacetate, l-lactate dehydrogenase (LDH, rabbit muscle), malate dehydrogenase (MDH, porcine heart), and Dowex® 1X8-200 ion exchange resin were from Sigma-Aldrich. Restriction enzymes, T4 DNA ligase, and Pfx polymerase were from Invitrogen or New England Biolabs (Pickering, Canada). All other chemicals were analytical grade and were obtained from Sigma-Aldrich or Fisher.
DNA Manipulation
DNA was purified, digested, and ligated using standard protocols (13). The HMG/CHA aldolase gene (pput1361) was amplified from genomic DNA of P. putida F1 by PCR using the primers with the sequences GCGGCATATGAACACTCTGATCGGTAAAAC and CCGCAAGCTTAACCCTCCAAGTCTTCG. Introduced NdeI and PstI restriction sites are underlined. The amplified fragment was ligated to the vector pT7-7 (14). Site-specific mutagenesis was carried out according to a modified QuikChangeTM (Stratagene) method. The sequence of the sense oligonucleotides used to construct the R123A and R123K mutants are GGAGTCGCGGACACCCAGACGTTACGCGACATGGGGTTC and GGAGTCAAGGACACCCAGACGTTACGCGACATGGGGTTC, respectively (the altered codons are underlined). All of the constructs were checked by sequencing at the Guelph Molecular Supercenter of the University of Guelph.
Purification of Wild-type and Mutant HMG/CHA Aldolase
Recombinant E. coli BL21(λDE3) harboring the gene encoding HMG/CHA aldolase was propagated in 1 liter of Luria-Bertani medium supplemented with 0.6 m d-sorbitol, 2.5 mm glycine betaine, and 100 μg/ml ampicillin at 37 °C until a density of 0.6 was reached at 600-nm wavelength, after which 0.5 mm isopropyl β-d-thiogalactopyranoside was added to induce protein expression. The culture was incubated at 15 °C overnight and then harvested by centrifugation at 5000 × g for 10 min.
Chromatography was performed on an ÄKTA Explorer 100 (Amersham Biosciences). Buffer containing 20 mm sodium HEPES, pH 7.5, was used throughout the purification procedure unless indicated otherwise.
The cell pellet (4.1 g of wet weight) was resuspended in buffer and disrupted by a French press. The cell debris was removed by centrifugation (17,500 × g, 10 min). The clear supernatant was filtered through a 0.45-μm filter and loaded onto a SourceTM 15Q (Amersham Biosciences) anion exchange column (2 × 13 cm). The column was washed with 2 column volumes of the buffer containing 0.15 m NaCl followed by a linear gradient of NaCl from 0.15 to 0.50 m over 12 column volumes. The aldolase was eluted with ∼0.35 m NaCl. Active fractions were pooled, concentrated by ultrafiltration with a YM10 filter (Millipore, Nepean, Canada), and loaded onto a phenyl-SepharoseTM hydrophobic interaction chromatography column (1 × 18.5 cm) and purified with a 5-column volume linear gradient of ammonium sulfate from 0.4 to 0 m. The enzyme was eluted at ∼0.2 m ammonium sulfate. Active fractions were concentrated to ∼4 ml by ultrafiltration, loaded onto a HiLoad 26/60 Superdex 200 prep gel filtration column (Amersham Biosciences), and then eluted with buffer containing 0.15 m NaCl. The purified enzyme was concentrated to 20 mg of protein/ml as before, aliquoted, and stored at −80 °C in 20 mm sodium HEPES buffer, pH 7.5. The enzyme remained stable for 2 months under this storage condition.
Determination of Protein Concentration, Purity, and Molecular Mass
Protein concentrations were determined by the Bradford assay (15) using bovine serum albumin as standards. SDS-PAGE was performed and stained with Coomassie Blue according to established procedures (15). The molecular weight of holoenzyme was determined by gel filtration using a HiLoad 26/60 Superdex 200 prep column.
Crystallization and Structure Determination
HMG/CHA aldolase crystals were grown using the hanging drop method at 25 °C, with 2 μl of reservoir solution containing 10% PEG 4000, 0.2 m ammonium acetate, 0.1 m sodium acetate, pH 4.6, 10 mm MgCl2, 5 mm sodium pyruvate, and 2 μl of 21 mg/ml HMG/CHA aldolase. The crystals were flash frozen in a 100 K liquid nitrogen stream using paratone-N oil as a cryoprotectant. The data were collected to 1.82 Å at the Canadian Macromolecular Crystallography Facility (08ID-1) and processed in HKL2000 (16). Crystals were of the trigonal space group R32, with cell dimensions a = b = 111.18 Å and c = 139.57 Å. The structure was determined using Phaser (17), searching with residues 2–157 of one protomer from the Mycobacterium tuberculosis RraA (MenG) structure (Protein Data Bank code 1NXJ); this solution was weak (LLG 41.4) but proved sufficient for structure refinement. The structure was rebuilt in Coot (18), and refinement was performed using Refmac in CCP4 (19). For the final stages of refinement, TLS refinement with five residue groups was added (20). The crystal contains a single protomer in the asymmetric unit, with residues 1 and 237–238 missing from the final model. Supplemental Table S1 lists data collection and final model refinement statistics. Structure figures were prepared using PyMol (21).
Preparation of Enzyme Substrates
HMG and CHA were synthesized chemically using published methods with some modifications (22). Racemic KHG and HOPA were synthesized enzymatically using HpaI according to previous methods (23). All of the products were purified using Dowex Chloride 1X8 anion exchange resin with a linear gradient of HCl from 0.0 to 0.1 m. Fractions containing specified products were collected and neutralized by 2.0 m NaOH, lyophilized, and stored at −20 °C. The concentration of each product was determined with HMG/CHA aldolase (using 1.0 mm CoCl2 as cofactor) by coupling pyruvate or oxaloacetate formation to NADH oxidation using LDH or MDH (for CHA), respectively.
Metal Substitution
Metal-free apoenzyme was prepared by adding 0.5 g of Chelex 100 (Sigma) to 10 mg of purified enzyme in 10 ml of 20 mm sodium HEPES, pH 7.5. After gentle stirring for 20 min, Chelex 100 was removed by a 20-μm filter. The apoenzyme has less than 1.0% of the activity observed in the presence of 1.0 mm MgCl2. The apoenzyme was preincubated with the stated metal ions prior to use in the kinetic assay.
Enzyme Assays
All of the kinetics assays were performed at least in duplicate at 25 °C using a Varian Cary 3 spectrophotometer equipped with a thermojacketed cuvette holder. HMG aldol cleavage and OAA decarboxylase activity were observed by coupling pyruvate formation to NADH oxidation using LDH. Analogously, formation of acetaldehyde by HOPA cleavage was monitored using alcohol dehydrogenase, and formation of oxaloacetate by CHA cleavage was monitored using MDH. NADH oxidation was monitored at 340 nm, and the extinction coefficient of NADH was taken to be 6200 m−1 cm−1. A standard aldolase cleavage activity assay contained 2.0 mm of substrate, 0.4 mm NADH, 1.0 mm divalent metal ion, and 30 units of either LDH, alcohol dehydrogenase, or MDH in 100 mm HEPES buffer, pH 8.0. For KHG aldol cleavage activity, glyoxylate formation was determined using phenylhydrazine hydrochloride according to the continuous spectrophotometric method (24). Assay solutions contained 4.0 mm phenylhydrazine hydrochloride, 1 mm divalent metal ion, and varying concentrations of KHG in 100 mm HEPES buffer, pH 8.0, with a total volume of 1.0 ml. Enzyme was added to initiate the reaction, and the absorbance increase at 324 nm was monitored for 5 min.
All of the kinetic data fitting was performed using nonlinear regression in the program Leonora (25). All of the data were fitted to the Michaelis-Menten equation, except for the OAA decarboxylation reaction, which was fitted to the substrate inhibition equation. For inhibition assays, the concentration of sodium oxalate was varied from 0.5 to 10 × Ki, and data were fitted to a competitive inhibition equation.
The pH dependence of the kinetics was determined using HMG as the substrate, with pH varying between pH 6.0 and 10.5 in a three-component constant ionic strength buffer containing 0.1 m Tris, 0.05 m acetic acid, and 0.05 m MES. The data were fitted by nonlinear regression in Leonora.
Pyruvate α-proton exchange was determined by measuring the loss of pyruvate methyl protons signal in deuterated buffer by 1H NMR (8). Proton exchange assays were performed using 600 μl of assay solution containing 30 mm of pyruvate, 1.0 mm MgCl2 in 20 mm deutered MOPS buffer, pD 8.0.
RESULTS
Expression and Purification
The HMG/CHA aldolase of P. putida F1 was overexpressed in E. coli BL21(λDE3) and purified to homogeneity with a typical yield of 19 mg of purified protein/liter of bacterial culture (supplemental Fig. S1 and supplemental Table S1). The subunit molecular mass of the enzyme as determined by SDS-PAGE is 26 kDa, consistent with the predicted molecular mass (25,448 Da).
Overall Structure
The structure of HMG/CHA aldolase was determined at 1.82 Å by molecular replacement using the structure of RraA (Protein Data Bank code 1NXJ) as a search model (Table 1). The protomer forms a four-layered α-β-β-α sandwich (Fig. 2A). One layer is a continuous seven-stranded sheet comprised of β11′, β1, β6, β2, β3, β4, and β5 (where the underlined strands are antiparallel to others, and β11′ is contributed by an adjacent protomer in the trimer). The other β-strand layer is comprised of β2, β9, and β10 and, separately, β7 and β8. αC, αD, and αE pack against the exposed face of the first sheet, whereas αA, αB, and the N-terminal portion of αF pack against the exposed face of the second sheet. The C-terminal-most 40 residues form an extended “tail” that wraps around an adjacent protomer of the trimer, with αF, αG, and αH packing against the symmetry related copies of αC and αD and β11′ hydrogen bonding with β1. The short 310I helix, found at the very C terminus of the chain, is formed by residues that exist only in the P. putida protein.
TABLE 1.
Data collection | |
Space group | R32 |
Unit cell dimensions | |
a = b (Å) | 111.18 |
c (Å) | 139.27 |
Wavelength (Å) | 1.541 |
Resolution limits (Å) | 50–1.82 |
Rsym | 0.099 (0.273) |
Total observations | 180,118 |
Unique observations | 27,093 |
Data completeness (%) | 90.8 (89.4) |
Redundancy | 6.7 (2.8) |
I/σI | 12.0 (4.4) |
Mean B (Wilson plot) | 28.5 |
Model refinement | |
Rcryst | 0.158 |
Rfree | 0.169 |
Root mean square deviations | |
Bond lengths (Å) | 0.009 |
Bond angles (°) | 1.20 |
Residues modeled | 2–236 |
Water molecules | 125 |
Mean B: protein | 34.4 |
Water | 46.8 |
Mg2+ | 24.4 |
Pyruvate | 26.1 |
PEG | 73.5 |
Oligomeric State
The crystal packs with a single molecule per asymmetric unit. This protomer is associated into a highly stabilized trimer, where each protomer buries 1724 Å2 with the adjacent protomer; much of this interface is due to the C-terminal extension. PISA calculates that this trimer is the most stable conformation (26). However, there is also a second candidate oligomeric interface where two trimeric rings interact, with a combined 760 Å2 buried per protomer with two protomers from the opposite ring (Fig. 2, B and C). Despite this limited buried surface, there are additional lines of evidence indicating that the hexamer is the true, in vivo state. The ring-ring interaction shows good shape complementarity, there is a well defined inter-ring hydrophobic patch in the vicinity of Ile-158, and the residues buried at the interface are far more conserved than those on exposed surfaces of the protomer. This proposed hexamer is consistent with a 146-kDa molecular mass determined experimentally by gel filtration.
Active Site Organization
The catalytic site is found in the cleft between adjacent protomers of the trimer and is comprised of residues contributed by helices αD, αE, the β4–αE and β5–β6 loops from one protomer, and αB and αF of the other. The electron density map shows a well ordered magnesium ion and pyruvate molecule bound in the active site (Fig. 2D). The magnesium ion displays skewed octahedral coordination geometry. Unusually, the metal ion has only a single direct protein ligand: Asp-124. Two additional coordination sites are occupied by pyruvate, and the remaining three sites are occupied by water molecules. These water molecules are tightly bound, however; one forms a hydrogen bond to Asp-124 carboxylate, one forms a hydrogen bond to the carboxylate groups of Asp-102 and Glu-199′, and the third forms a hydrogen bond to Glu-199′ alone, which is contributed by αF from an adjacent protomer that covers the catalytic site. This helix is stabilized at its N- and C-terminal ends by hydrophobic interactions, but the central two turns are suspended over the catalytic site and solvent-exposed on all sides.
The pyruvate group coordinates the magnesium ion through its keto and one carboxylate oxygen atoms. The pyruvyl carboxylate group also forms a pair of hydrogen bonds with the main chain amide nitrogen atoms of Leu-103 and Leu-104, located at the N-terminal end of αD, whose helix dipole points into the catalytic site. The carbonyl oxygen of pyruvate forms an additional hydrogen bond with the Nϵ guanadinium nitrogen of Arg-123. Arg-123, in turn, makes a salt bridge with Glu-36. The flat face of the pyruvate stacks against the main chain atoms of Phe-100 and Gly-101. An additional well ordered water molecule (Wat-4) makes a hydrogen bond (2.8 Å) with the pyruvate methyl group. The ability of the methyl group to act as a hydrogen bond donor reflects the strongly electronegative nature of this methyl carbon atom in the context of the pyruvate·Mg2+ complex.
Substrate Modeling
Superposing the pyruvyl moiety of CHA on the experimentally observed pyruvate-binding site allows the rest of the CHA to be modeled by adjusting primarily three torsion angles (Fig. 2E). In our model, the C4-OH interacts with Arg-123Nη2 and the metal ligating water molecule, Wat-1, which in turn hydrogen bonds with Glu-199′. The C4-carboxylate hydrogen bonds with Thr-145Oγ. These interactions would all be expected to be recapitulated in the HMG complex. The C6-carboxylate specific to CHA makes a hydrogen bond with Asn-71Nδ and could potentially also hydrogen bond with Lys-147 Nζ, although this would require a slight reorientation of this residue. All of the amino acid residues modeled as contacting the substrate are conserved in all homologous HMG/CHA aldolases (supplemental Fig. S3).
Structurally Related Proteins
Searching the Protein Data Bank with DALI-lite reveals a number of related structures (Fig. 2, F and G, and supplemental Table S2). There are two relatively close structural homologs to HMG/CHA aldolase that are functionally uncharacterized: PSPTO_3204 (Protein Data Bank code 3K4I) from Pseudomonas syringae pv. tomato DC3000 and YER010c (Protein Data Bank code 2C5Q) from Saccharomyces cerevisiae (11). The closest related protein with an established function is the RNaseE inhibitor RraA from E. coli (Protein Data Bank code 1Q5X) (10), along with its homologs from M. tuberculosis (Protein Data Bank code 1NXJ) (27), Pseudomonas aeruginosa (Protein Data Bank code 3C8O), Thermus thermophilus (Protein Data Bank code 1J3L) (28), and Vibrio cholerae (Protein Data Bank code 1VI4). These RraA homologs omit the first 30 and last 40 amino acids (the C-terminal tail) of HMG/CHA aldolase and are therefore noticeably smaller. The HMG/CHA aldolase structure is also distantly related to His domain of enzyme I for bacterial P-enolpyruvate-dependent carbohydrate:phosphotransferase systems (Protein Data Bank codes 1ZYM and 2HWG) (29, 30) and the phosphotransfer domain of pyruvate phosphate dikinase (Protein Data Bank code 1DIK) (31).
Metal Ion and Substrate Specificity of HMG/CHA Aldolase
The specific activities of purified apoenzyme with different metal ions were determined using HMG as substrate. Optimum activity was obtained with Mg2+ and Mn2+ ions, and other divalent cations activate the enzyme in the following order of effectiveness: Co2+ > Zn2+ > Ni2+ > Cd2+. No detectable activity was observed for Cu2+ and Ca2+ (Table 2).
TABLE 2.
Metal ion | Relative activity |
---|---|
% | |
Mg2+ | 100.0 ± 2.8 |
Mn2+ | 90.3 ± 5.7 |
Co2+ | 64.7 ± 3.6 |
Ni2+ | 28.2 ± 3.4 |
Cd2+ | 5.0 ± 0.2 |
Zn2+ | 49.6 ± 2.7 |
Cu2+ | ND |
Ca2+ | ND |
EDTA | ND |
Using Mg2+ or Mn2+ as cofactors, the substrate specificity of HMG/CHA aldolase toward different 4-hydroxy-2-ketoacids was determined (Table 3). The enzyme has the highest specificity constant (kcat/Km) for CHA and HMG. The specificity constant for HOPA, a substrate analog that lacks the 4-carboxylate group, is decreased by a factor of ∼104-fold relative to the physiological substrate, HMG. The enzyme also exhibits oxaloacetate decarboxylase activity, which also involves C–C bond cleavage, leading to formation of pyruvate and carbon dioxide. The kinetic data for all substrates obey classic Michaelis-Menten kinetics except for OAA, which follows a substrate inhibition model.
TABLE 3.
Substrate | 1.0 mm Mg2+ |
1.0 mm Mn2+ |
||||||
---|---|---|---|---|---|---|---|---|
Km | Ksi | kcat | kcat/Km | Km | Ksi | kcat | kcat/Km | |
mm | mm | s−1 | m−1·s−1 | mm | mm | s−1 | m−1·s−1 | |
OAA | 0.30 ± 0.03 | 0.37 ± 0.04 | 1.85 ± 0.18 | 6.2 × 103 | 0.036 ± 0.004 | 0.25 ± 0.03 | 1.52 ± 0.09 | 4.2 × 104 |
HMG | 0.26 ± 0.02 | a | 19.3 ± 0.9 | 7.4 × 104 | 0.022 ± 0.001 | a | 13.7 ± 0.2 | 6.2 × 105 |
CHA | 0.066 ± 0.008 | a | 14.4 ± 0.5 | 2.2 × 105 | 0.030 ± 0.005 | a | 7.5 ± 0.3 | 2.5 × 105 |
KHG | 0.15 ± 0.02 | a | 0.058 ± 0.002 | 3.8 × 102 | 0.071 ± 0.003 | a | 0.25 ± 0.003 | 3.5 × 103 |
HOPA | 25.0 ± 2.2 | a | 0.048 ± 0.003 | 1.9 | 8.8 ± 0.7 | a | 0.19 ± 0.01 | 2.2 × 101 |
a Substrate inhibition was not observed.
Pyruvate Proton Exchange and Aldolase pH Rate Profile
The enzyme is able to catalyze the exchange of pyruvate α-proton with a rate of 2.98 ± 0.18 s−1 as determined by 1H NMR in deuterated buffer. Furthermore, sodium oxalate is a strong competitive inhibitor of the HMG aldolase activity with a Ki value of 5.0 ± 0.3 μm using 1.0 mm MgCl2 as a cofactor (supplemental Fig. S2A) and 1.7 ± 0.1 μm using 1.0 mm MnCl2 as a cofactor (supplemental Fig. S2B).
A pH activity profile for HMG cleavage was determined using constant ionic strength buffers from pH of 6.0 to 10.5, with 1.0 mm MgCl2 as cofactor (supplemental Fig. S4). Kinetic parameters were not determined above pH 10.5 because of the instability of substrate at high pH. The kcat/Km and kcat data for the enzyme is consistent with a single deprotonation with pKa values of 8.0 ± 0.1 and 7.0 ± 0.1 for free enzyme and enzyme substrate complex, respectively.
Characterization of the R123A and R123K Variants
Arg-123 was separately replaced with alanine and lysine by site-directed mutagenesis. The R123A mutant proved unable to catalyze pyruvate C3-proton exchange, OAA decarboxylation, and the HMG or CHA aldol cleavage reactions. The R123K variant, on the other hand, retains some HMG aldol cleavage activity (Km value of 5.5 ± 0.4 mm, kcat value of 0.099 ± 0.001 s−1), although its catalytic efficiency (kcat/Km) toward HMG is decreased by 4000-fold. This is mainly due to a 200-fold decrease in kcat. Pyruvate proton exchange rate was also reduced by ∼200-fold in the R123K variant (0.015 ± 0.003 s−1).
DISCUSSION
Bacterial aromatic meta-cleavage pathways follow a general schema wherein a series of steps following aromatic ring cleavage culminates in the formation of a 4-hydroxy-2-ketoacid; this molecule is then cleaved by an aldolase into pyruvate and an aldehyde or ketoacid that is suitable for entry into central metabolism. The HMG/CHA pyruvate aldolase, in particular, catalyzes the last step of protocatechuate 4,5-cleavage pathway. The enzyme adopts a four-layered α-β-β-α sandwich structure with the active site in the interface of two adjacent subunits of the hexamer; this fold has not been previously reported for an aldolase. Two other Class II pyruvate aldolases (HpaI and DmpG) in aromatic meta-cleavage pathway (32, 33), along with fructose 1,6-bisphosphate aldolases (34), dihydropteroate synthetases (35), and 3-deoxy-d-manno-octulosonate 8-phosphate synthase (36) all adopt TIM barrel folds. In addition, three-layered α-β-α sandwich structures are reported for l-fuculose-1-phosphate aldolase (37) and rhamnulose-1-phosphate aldolase (38).
In canonical Class II aldolases, the mechanism proceeds via the base-catalyzed abstraction of a proton from the hydroxyl group at the C4 position, cleavage of the carbon-carbon bond, and formation of an enolate intermediate stabilized by a divalent metal ion (39). Protonation of this intermediate forms pyruvate, completing the reaction. The magnesium ion in the HMG/CHA aldolase structure is coordinated directly by Asp-124, and indirectly by Asp-102 and Glu-199′ (from a different protomer), which together position three water molecules that directly bind the metal cofactor. This arrangement most strongly resembles HpaI, where the magnesium ion is bound directly by the acidic residues Glu-149 and Asp-175, whereas Glu-44 is an indirect ligand (Fig. 3B) (33). Coordinating this metal ion via the C1-carboxyl and C2-carbonyl groups is a well ordered pyruvate molecule with similar arrangements observed in other pyruvate aldolases containing bound pyruvate analogs (32, 33).
We have shown here that HMG/CHA aldolase catalyzes two reactions: pyruvate C3-proton exchange and oxaloacetate decarboxylation, in addition to HMG and CHA cleavage. All of these reactions require the formation of a pyruvate enolate intermediate. Both HpaI and BphI (56% sequence identity to DmpG) also exhibit pyruvate C3-proton exchange and secondary decarboxylase activity (8, 40), supporting the existence of a common pyruvate enolate intermediate in all three aldolases (5, 7). The presence of this intermediate in these reactions is further supported by oxalate, a pyruvate enolate analog, being a strong competitive inhibitor.
In addition to the pyruvate coordinating metal ion (which characterizes all Class II aldolases), Arg-123 appears to be a functionally critical group. In the pyruvate complex structure it forms a strong hydrogen bond with the pyruvate keto group, and the 200-fold reduction in the α-proton exchange rate in the R123K mutant argues that precise positioning of this hydrogen bond is critical for stabilizing the enolate intermediate. Modeling of the full substrate suggests that this residue also hydrogen bonds to the C4-OH group (Fig. 2E). In the C4-OH deprotonation step, Arg-123 is therefore predicted to stabilize the negative charge that develops on the C4-O−, thus promoting proton abstraction.
Both the kcat/Km and kcat data indicate a single deprotonation event with pKa values of 8.0 ± 0.1 and 7.0 ± 0.1 for free enzyme and enzyme substrate complex, respectively. These pKa values are consistent with a base catalyzed deprotonation of the C4-OH of the substrate leading to the aldol cleavage reaction. The base in this proton abstraction is almost certainly the metal-bound water, Wat-1 (Fig. 4A). This group is well positioned to hydrogen bond with C4-OH (2.9 Å), while also interacting with the magnesium ion (which can act as a Lewis acid, stabilizing the hydroxyl ion) and Glu-199′ (which could possibly act in concert with Wat-1 in a proton relay). During the subsequent cleavage of the C3–C4 bond, and the concomitant formation of the enolate intermediate, the hydrogen bond between Arg-123 and the C2 keto oxygen would stabilize the development of a negative charge on this atom (Fig. 4B). This critical dual role for Arg-123 is supported by the finding that replacement with Lys results in an enzyme with greatly reduced activity (indicating that both H-bond-donating groups are likely needed), whereas replacement with Ala results in a protein that is wholly inactive. The disruption of the pyruvate C3 deuterium exchange and the OAA decarboxylation reactions in addition to HMG cleavage supports the idea that Arg-123 is especially important for stabilizing the enolate anion. Intriguingly, in the active sites of both HpaI and DmpG, an arginine residue is positioned to present a pair of guanylate nitrogen atoms in nearly identical (relative to pyruvate) positions (Fig. 3). In HpaI, replacement of Arg-70 with an alanine residue also abolishes aldolase activity. Together, these common features in HMG/CHA, HpaI, and DmpG aldolases point toward the convergent evolution of a common catalytic mechanism. Other enzymes that also proceed through a metal ion-assisted 2-ketoacid enolization reaction step, such as oxaloacetate decarboxylase (PA4872) (41) and 5,10-methylenetetrahydrofolate:3-methyl-2-oxobutanoate hydroxymethyl transferase (42), also have arginine residues (Arg-159 for PA4872 and Arg-228 for KPHMT from M. tuberculosis) interacting with the equivalent substrate keto group in their active sites.
The final step of the cleavage reaction is protonation of the pyruvate enolate, forming pyruvate (Fig. 4C). The experimental, pyruvate-bound structure represents the product of this reaction, and Wat-4 (which forms a 2.8 Å hydrogen bond with the methyl hydrogen) is the only observed nearby group capable of proton donation (Fig. 2D). Although this water is likely a relatively poor acid (there are no nearby charged residues to stabilize a hydroxide or hydronium ion), the relatively slow nature of this step means that it should still suffice to explain the observed catalytic rate.
Despite the acidic metal ion-binding pocket, the presence of the magnesium ion and multiple cationic residues (Arg-40, Arg-123, Arg-195, Arg-203, Lys-147, and Lys-202) result in the active site being generally electropositive. This likely contributes to the specificity of the enzyme toward substrates with 4-carboxylate substitutions, such as HMG and CHA. Additional interactions of the substrate with conserved residues including Thr-145, Asn-71, and Lys-147 are probably important for the C4–C6 moiety of CHA binding and correctly positioning the substrate. This area may also be a second position for nonproductive OAA binding, accounting for the substrate inhibition kinetics for OAA decarboxylation activity (Table 3). In general, substrate recognition does not appear to involve tight interactions, resulting in the relative broad substrate specificity of the enzyme.
The structural and mechanistic insight afforded by this study also sheds light on several related proteins whose functions are poorly understood. For example, the structure of YER010c, from S. cerevisiae was reported, but whereas the hypothesis of it being a methyltransferase was discounted (11), a more plausible function has not been demonstrated. Even more closely related is PSPTO_3204 (Protein Data Bank code 3K4I) from P. syringae pv. tomato DC3000, which was recently deposited at the Protein Data Bank but without an ascribed function. Most of the key catalytic machinery identified in HMG/CHA aldolase, including the metal ligands Asp-102 (although not in YER010c), Asp-124, and Glu-199′, the keto binding Arg-123 along with Glu-36, as well as the residues contributed by αd, have direct correlates in YER010c and PSPTO_3204 (Fig. 2G and supplemental Fig. S5). Interestingly, a magnesium ion in the PSPTO_3204 structure is ligated directly to Asp-102 and Glu-200 and indirectly to Asp-124. This position is shifted ∼3 Å relative to HMG/CHA aldolase and appears incompatible with productive pyruvate binding. In both of these enzymes, a deep binding pocket is present, but loop rearrangements and residue replacements result in the binding sites being quite different, suggesting the recognition of quite different substrates. Nevertheless, the strong conservation of the magnesium and pyruvate-binding sites in these two proteins argues that they too are highly likely to be aldolases.
The similarity between HMG/CHA aldolase and RraA is less strong. RraA from E. coli is proposed to bind the C-terminal domain of RNase E, blocking binding of accessory proteins involved in the RNA degradosome function (43, 44). RraA is also trimeric but, relative to HMG/CHA aldolase, lacks several motifs (supplemental Fig. S5), including the αF helix that contributes the metal ligand Glu-199′. The equivalent of Arg-123 is conserved across all RraA homologs, whereas Asp-102 and Asp-124 are also largely conserved, although one or both are missing in some homologs, including E. coli and T. thermophilus. Interestingly, the proposed substrate-binding residues Asn-71 and Lys-147 are conserved, despite RraA being relatively distantly related to HMG/CHA aldolase. The pyruvate-binding site is occupied by small anions in several of these structures, including tartaric acid (Protein Data Bank code 1NXJ) and acetate (Protein Data Bank code 2PCN). RraA is present in organisms such as T. thermophilus (28) where RNase E is absent, suggesting that the inhibitory function of RraA may have been secondarily acquired, and some homologs may have a catalytic function in addition to, or instead of, the RNase E inhibitory function. The similarities with the active site of HMG/CHA aldolase suggests that the RraA family is derived from a common ancestor with class II aldolase activity, and at least some homologs seem likely to have retained this activity. In addition, HMG/CHA aldolase is also distantly related to the His domain of Enzyme I and phosphohistidine domain of PPDK in terms of the three-dimensional structure. Intriguingly, the histidine residues responsible for phosphate transfer (His-189 for enzyme I and His-455 for PPDK) were replaced by arginine (Arg-123) in HMG/CHA aldolase, which is essential for catalysis. Future work on these proteins may provide deeper insights into how these divergent functions evolved from a common ancestor.
Supplementary Material
Acknowledgment
We thank Pawel Grochulski for collecting the HMG/CHA aldolase dataset at the Canadian Macromolecular Crystallography Facility.
This work was supported by National Science and Engineering Research Council of Canada Discovery Grants 238284 (to S. Y. K. S.) and 327280 (to M. S. K.).
The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2 and Figs. S1–S5.
The atomic coordinates and structure factors (code 3NOJ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
- HMG
- 4-hydroxy-4-methyl-2-oxoglutarate or 2-hydroxy-2-methyl-4-oxopentanedioic acid
- CHA
- 4-carboxy-4-hydroxy-2-oxoadipic acid or 2-hydroxy-4-oxobutane-1,2,4-tricarboxylic
- KHG
- α-keto-γ-hydroxyglutarate or 2-hydroxy-4-oxopentanedioic acid
- HOPA
- 4-hydroxy-2-oxopentanoate
- LDH
- l-lactate dehydrogenase
- MDH
- malic dehydrogenase
- MOPS
- 3-(N-morpholino) propanesulfonic acid
- MES
- 2-(N-morpholine)ethanesulfonic acid
- OAA
- oxaloacetate.
REFERENCES
- 1.Masai E., Katayama Y., Fukuda M. (2007) Biosci. Biotechnol. Biochem. 71, 1–15 [DOI] [PubMed] [Google Scholar]
- 2.Seo J. S., Keum Y. S., Li Q. X. (2009) Int. J. Environ. Res. Public Health 6, 278–309 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Keyser P., Pujar B. G., Eaton R. W., Ribbons D. W. (1976) Environ. Health Perspect. 18, 159–166 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dennis D. A., Chapman P. J., Dagley S. (1973) J. Bacteriol. 113, 521–523 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tack B. F., Chapman P. J., Dagley S. (1972) J. Biol. Chem. 247, 6444–6449 [PubMed] [Google Scholar]
- 6.Maruyama K. (1990) J. Biochem. 108, 327–333 [DOI] [PubMed] [Google Scholar]
- 7.Maruyama K., Miwa M., Tsujii N., Nagai T., Tomita N., Harada T., Sobajima H., Sugisaki H. (2001) Biosci. Biotechnol. Biochem. 65, 2701–2709 [DOI] [PubMed] [Google Scholar]
- 8.Wang W., Seah S. Y. (2005) Biochemistry 44, 9447–9455 [DOI] [PubMed] [Google Scholar]
- 9.Powlowski J., Sahlman L., Shingler V. (1993) J. Bacteriol. 175, 377–385 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Monzingo A. F., Gao J., Qiu J., Georgiou G., Robertus J. D. (2003) J. Mol. Biol. 332, 1015–1024 [DOI] [PubMed] [Google Scholar]
- 11.Leulliot N., Quevillon-Cheruel S., Graille M., Schiltz M., Blondeau K., Janin J., Van Tilbeurgh H. (2005) Protein Sci. 14, 2751–2758 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Clapés P., Fessner W. D., Sprenger G. A., Samland A. K. (2010) Curr. Opin. Chem. Biol. 14, 154–167 [DOI] [PubMed] [Google Scholar]
- 13.Sambrook J., Fritsch E. F., Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York [Google Scholar]
- 14.Tabor S., Richardson C. C. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 1074–1078 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bradford M. M. (1976) Anal. Biochem. 72, 248–254 [DOI] [PubMed] [Google Scholar]
- 16.Otwinowski Z., Minor W. (1997) Methods Enzymol. 276, 307–326 [DOI] [PubMed] [Google Scholar]
- 17.McCoy A. J., Grosse-Kunstleve R. W., Adams P. D., Winn M. D., Storoni L. C., Read R. J. (2007) J. Appl. Crystallogr. 40, 658–674 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Emsley P., Lohkamp B., Scott W. G., Cowtan K. (2010) Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Collaborative Computational Project (1994) Acta Crystallogr. D Biol. Crystallogr. 50, 760–76315299374 [Google Scholar]
- 20.Winn M. D., Isupov M. N., Murshudov G. N. (2001) Acta Crystallogr. D Biol. Crystallogr. 57, 122–133 [DOI] [PubMed] [Google Scholar]
- 21.Delano W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific, San Carlos, CA [Google Scholar]
- 22.Helaine V., Rossi J., Gefflaut T., Alaux S., Bolte J. (2001) Adv. Synth. Catalysis 343, 692–697 [Google Scholar]
- 23.Wang W., Baker P., Seah S. Y. (2010) Biochemistry 49, 3774–3782 [DOI] [PubMed] [Google Scholar]
- 24.Chell R. M., Sundaram T. K., Wilkinson A. E. (1978) Biochem. J. 173, 165–177 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Cornish-Bowden A. (1995) Analysis of Enzyme Kinetic Data, Oxford University Press, New York [Google Scholar]
- 26.Krissinel E., Henrick K. (2007) J. Mol. Biol. 372, 774–797 [DOI] [PubMed] [Google Scholar]
- 27.Johnston J. M., Arcus V. L., Morton C. J., Parker M. W., Baker E. N. (2003) J. Bacteriol. 185, 4057–4065 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Rehse P. H., Kuroishi C., Tahirov T. H. (2004) Acta Crystallogr. D Biol. Crystallogr. 60, 1997–2002 [DOI] [PubMed] [Google Scholar]
- 29.Liao D. I., Silverton E., Seok Y. J., Lee B. R., Peterkofsky A., Davies D. R. (1996) Structure 4, 861–872 [DOI] [PubMed] [Google Scholar]
- 30.Teplyakov A., Lim K., Zhu P. P., Kapadia G., Chen C. C., Schwartz J., Howard A., Reddy P. T., Peterkofsky A., Herzberg O. (2006) Proc. Natl. Acad. Sci. U.S.A. 103, 16218–16223 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Herzberg O., Chen C. C., Kapadia G., McGuire M., Carroll L. J., Noh S. J., Dunaway-Mariano D. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 2652–2657 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Manjasetty B. A., Powlowski J., Vrielink A. (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 6992–6997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Rea D., Fülöp V., Bugg T. D., Roper D. I. (2007) J. Mol. Biol. 373, 866–876 [DOI] [PubMed] [Google Scholar]
- 34.Blom N. S., Tétreault S., Coulombe R., Sygusch J. (1996) Nat. Struct. Biol. 3, 856–862 [DOI] [PubMed] [Google Scholar]
- 35.Hampele I. C., D'Arcy A., Dale G. E., Kostrewa D., Nielsen J., Oefner C., Page M. G., Schönfeld H. J., Stüber D., Then R. L. (1997) J. Mol. Biol. 268, 21–30 [DOI] [PubMed] [Google Scholar]
- 36.Radaev S., Dastidar P., Patel M., Woodard R. W., Gatti D. L. (2000) J. Biol. Chem. 275, 9476–9484 [DOI] [PubMed] [Google Scholar]
- 37.Dreyer M. K., Schulz G. E. (1993) J. Mol. Biol. 231, 549–553 [DOI] [PubMed] [Google Scholar]
- 38.Kroemer M., Merkel I., Schulz G. E. (2003) Biochemistry 42, 10560–10568 [DOI] [PubMed] [Google Scholar]
- 39.Horecker B. L., Tsolas O., Lai C. Y. (1972) in The Enzymes (Boyer P. D. ed) 3rd Ed., Vol. 7, pp. 213–258, Academic Press, New York [Google Scholar]
- 40.Baker P., Pan D., Carere J., Rossi A., Wang W., Seah S. Y. (2009) Biochemistry 48, 6551–6558 [DOI] [PubMed] [Google Scholar]
- 41.Narayanan B. C., Niu W., Han Y., Zou J., Mariano P. S., Dunaway-Mariano D., Herzberg O. (2008) Biochemistry 47, 167–182 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Chaudhuri B. N., Sawaya M. R., Kim C. Y., Waldo G. S., Park M. S., Terwilliger T. C., Yeates T. O. (2003) Structure 11, 753–764 [DOI] [PubMed] [Google Scholar]
- 43.Górna M. W., Pietras Z., Tsai Y. C., Callaghan A. J., Hernández H., Robinson C. V., Luisi B. F. (2010) RNA 16, 553–562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lee K., Zhan X., Gao J., Qiu J., Feng Y., Meganathan R., Cohen S. N., Georgiou G. (2003) Cell 114, 623–634 [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.